Transposon Therapeutics

Transposon Therapeutics, Inc.

San Diego, United States · Founded 2020 · $9.7M raised

Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$9.7M
Last Round
$5.0M GrantJul 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Biotech company developing LINE-1 reverse transcriptase inhibitors including TPN-101 for rare neurological diseases such as PSP and ALS.

Summary

Transposon Therapeutics is a Biotech company based in San Diego, United States, founded in 2020. It has raised $9.7M in total across 2 rounds, most recently a $5.0M Grant round in Jul 2025. Investors include Alzheimer's Drug Discovery Foundation and Canaan Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJul 2025
$5.0M

Sign up to see all 2 events

Funding: Series A through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Transposon Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/transposon-therapeutics"><img src="https://indexed.vc/api/badge/company/transposon-therapeutics" alt="Transposon Therapeutics on Indexed.vc" width="260" height="76" /></a>